Neurocrine Biosciences
NBIX
#1442
Rank
NZ$27.35 B
Marketcap
NZ$269.13
Share price
-2.30%
Change (1 day)
29.33%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Quarterly Reports

Thumbnail Neurocrine Biosciences
 Quarterly Report 2026-q1

Quarterly Report 2026-q1

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences
 Quarterly Report 2025-q2

Quarterly Report 2025-q2

Language: English

View Quarterly Report
Thumbnail Neurocrine Biosciences
 Quarterly Report 2025-q1

Quarterly Report 2025-q1

Language: English

View Quarterly Report